课题基金 / 基金详情

项目摘要

项目成果

Deborah N Chadee的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Mixed lineage kinase 3 (MLK3) is a mitogen-activated protein kinase kinase kinase (MAP3K) that regulates multiple MAPK signaling pathways. As a MAP3K, MLK3 phosphorylates MAP2Ks, which in turn activate c-Jun N-terminal Kinase (JNK) and p38 MAPKs to regulate stress-signaling responses. Through a kinase- independent scaffold function, MLK3 also activates B-Raf and extracellular signal-regulated kinase (ERK) signaling to promote cell proliferation. MLK3 is also critical for the migration and invasion of human ovarian, gastrointestinal, lung, and breast cancer cells. The LATS1 and 2 tumor suppressors are Ser/Thr kinases that control cellular responses including proliferation, migration, apoptosis and gene transcription. Loss of function of either LATS1 or LATS2 occurs in different types of tumors including ovarian, leukemia, prostate, breast, lung, and esophageal cancer. We identified that LATS1 phosphorylates MLK3 and promotes MLK3-14-3-3 binding, and we propose that this interaction results in retention of MLK3 in the cytoplasm. Accordingly, we observed that MLK3 is predominantly nuclear in ovarian cancer cells which have minimal functional LATS, and predominantly cytoplasmic in normal, ovarian epithelial cells that have functional LATS. Furthermore, our preliminary findings indicate that LATS together with β-TRCP regulate ubiquitination and turnover of MLK3. Our central hypothesis is that in ovarian epithelial cells, LATS phosphorylation of MLK3 promotes MLK3-14-3-3 binding and cytoplasmic retention, and also controls MLK3 protein turnover by mediating β-TRCP-dependent ubiquitination and degradation of MLK3. We postulate that in cells that lack functional LATS, MLK3 protein is aberrantly localized to the nucleus, and this results in inappropriate MLK3 interactions and signaling, which drives cellular transformation and tumorigenesis. The major focus of this research is to decipher the mechanism(s) by which LATS1 regulates MLK3 protein subcellular localization and turnover, and to investigate whether nuclear MLK3 drives cellular transformation of ovarian epithelial cells. Accordingly the specific aims of the proposal are: 1) To investigate how LATS and 14-3-3 regulate MLK3 localization 2) To analyze the regulation of MLK3 protein turnover by LATS, CK1ε and β-TrCP, and 3) To investigate whether nuclear MLK3 drives cellular transformation. These results will allow us to gain an understanding of how LATS regulates MLK3 in normal ovarian epithelial cells, and how loss of this regulation promotes aberrant MLK3 localization and heightened MLK3 protein, that drives cellular transformation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Cadherins by MLK3
  • 批准号:
    10793060
  • 项目类别:
  • 资助金额:
    $45.15万
  • 财政年份:
    2023
  • 负责人:
    Deborah N Chadee
  • 依托单位:
Regulation of MLK3 by LATS
  • 批准号:
    10056321
  • 项目类别:
  • 资助金额:
    $15.81万
  • 财政年份:
    2019
  • 负责人:
    Deborah N Chadee
  • 依托单位:
Regulation of MLK3 by oxidative stress in colon cancer cells
  • 批准号:
    9097305
  • 项目类别:
  • 资助金额:
    $44.25万
  • 财政年份:
    2016
  • 负责人:
    Deborah N Chadee
  • 依托单位:
MLK4 regulation of MAPK signaling
  • 批准号:
    8366331
  • 项目类别:
  • 资助金额:
    $34.92万
  • 财政年份:
    2012
  • 负责人:
    Deborah N Chadee
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: